9 March 2023

READ MOREAkston Biosciences Strengthens Board with Addition of John T. Preston

9 February 2021

READ MOREAkston Biosciences Completes Second Licensing and Supply Agreement with Dechra Pharmaceuticals PLC

22 July 2020

READ MOREAkston Biosciences Receives $2.5M Milestone Payment

9 April 2020

READ MOREAkston Biosciences Completes Series E Preferred Stock Financing

2 August 2019

READ MOREAkston Biosciences Completes Licensing and Supply Agreement with Dechra Pharmaceuticals PLC

26 May 2019

READ MOREAkston Biosciences Begins Buildout of New GMP Biologics Manufacturing Facility

10 May 2019

READ MOREAkston Biosciences Completes Convertible Note Financing

17 May 2018

READ MOREAkston Biosciences Completes Series D Preferred Stock Financing

8 March 2023

READ MOREAkston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA

1 November 2022

READ MOREAkston Biosciences Announces Positive Interim Phase II Results from COVID “Universal” Booster Vaccine Trial